Literature DB >> 26154574

Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients.

Benjamin Weixler1, Rene Warschkow, Andreas Zettl, Hans-Martin Riehle, Ulrich Guller, Carsten T Viehl, Markus Zuber.   

Abstract

INTRODUCTION: Small nodal tumor infiltrates (SNTI)-defined as isolated tumor cells and micrometastases-are associated with worse disease-free and overall survival in stage I and II colon cancer patients. Their detection, however, remains challenging. The objective of the present study was to evaluate whether there is a correlation between the location of SNTI and phagocytosed carbon dye particles in sentinel lymph nodes (SLN) of colon cancer patients.
MATERIALS AND METHODS: Isosulfan blue and carbon dye were injected intraoperatively near the tumor to mark the SLN. Serial sections of SLN were stained with hematoxylin-eosin and immunohistochemistry. Intranodal distribution of phagocytosed carbon particles was compared to the presence of SNTI.
RESULTS: Of a cohort of 159 patients, 24 patients had SNTI in their lymph nodes (LN). SNTI were found in a total of 116 LN of which 66 were SLN and 50 were non-SLN. In 59, these 116 LN with SNTI phagocytosed carbon dye were found (50.9 %). Phagocytosed carbon dye was identified significantly more often in SLN (49 of 66 SNTI positive SLN) compared to 10 of 50 SNTI positive non-SLN (p < 0.001). In 52 out of 59 LN (88.1 %), phagocytosed carbon dye was in close proximity to SNTI.
CONCLUSIONS: In the majority of patients, SNTI are located in the same SLN compartment as phagocytosed carbon dye particles. Our investigation provides evidence that the use of carbon dye facilitates SNTI detection and improves LN staging in colon cancer. Therefore, the concept of intranodal mapping-which has been previously described for melanoma-can be extended to colon cancer patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26154574     DOI: 10.1007/s00268-015-3130-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  30 in total

1.  United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer.

Authors:  Aviram Nissan; Mladjan Protic; Anton J Bilchik; Robin S Howard; George E Peoples; Alexander Stojadinovic
Journal:  Ann Surg       Date:  2012-09       Impact factor: 12.969

Review 2.  Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients.

Authors:  Stanley P L Leong; Markus Zuber; Robert L Ferris; Yuko Kitagawa; Ramon Cabanas; Charles Levenback; Mark Faries; Sukamal Saha
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

Review 3.  Detection and prognostic impact of micrometastasis in colorectal cancer.

Authors:  Saad Sirop; Mohammed Kanaan; Alpesh Korant; David Wiese; David Eilender; Sunil Nagpal; Madan Arora; Trevor Singh; Sukamal Saha
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

4.  Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.

Authors:  A J Bilchik; S Saha; D Wiese; J A Stonecypher; T F Wood; S Sostrin; R R Turner; H J Wang; D L Morton; D S Hoon
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

5.  The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis.

Authors:  Douglas Iddings; Aziz Ahmad; David Elashoff; Anton Bilchik
Journal:  Ann Surg Oncol       Date:  2006-09-29       Impact factor: 5.344

6.  Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer.

Authors:  Claudia Mescoli; Laura Albertoni; Salvatore Pucciarelli; Luciano Giacomelli; Valentina M Russo; Matteo Fassan; Donato Nitti; Massimo Rugge
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

7.  Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

Authors:  T E Le Voyer; E R Sigurdson; A L Hanlon; R J Mayer; J S Macdonald; P J Catalano; D G Haller
Journal:  J Clin Oncol       Date:  2003-08-01       Impact factor: 44.544

8.  Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial.

Authors:  Kazuo Koyanagi; Anton J Bilchik; Sukamal Saha; Roderick R Turner; David Wiese; Martin McCarter; Perry Shen; Linda Deacon; David Elashoff; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

9.  Carbon dye staining of sentinel lymph nodes facilitates microstaging of colon cancer patients.

Authors:  Carsten T Viehl; Ulrich Guller; Christian T Hamel; Hans-Martin Riehle; Christian Plaass; Walter R Marti; Daniel Oertli; Markus Zuber
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

10.  Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.

Authors:  Alexander Stojadinovic; Aviram Nissan; Mladjan Protic; Carol F Adair; Diana Prus; Slavica Usaj; Robin S Howard; Dragan Radovanovic; Milan Breberina; Craig D Shriver; Ronit Grinbaum; Jeffery M Nelson; Tommy A Brown; Herbert R Freund; John F Potter; Tamar Peretz; George E Peoples
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

View more
  2 in total

1.  Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.

Authors:  Benjamin Weixler; Andreas Rickenbacher; Dimitri Aristotle Raptis; Carsten T Viehl; Ulrich Guller; Jessica Rueff; Andreas Zettl; Markus Zuber
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

2.  Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study.

Authors:  Benjamin Weixler; Carsten T Viehl; Rene Warschkow; Ulrich Guller; Michaela Ramser; Guido Sauter; Markus Zuber
Journal:  JAMA Surg       Date:  2017-10-01       Impact factor: 14.766

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.